Aquatic Capital Management’s NeoGenomics NEO Stock Holding History

Aquatic Capital Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,668	Closed	-$149K	–	1672
2025 Q4	$149K	Buy	+12,668	New	+$137K	﹤0.01%	1066
2025 Q3	–	Sell	-16,306	Closed	-$119K	–	1566
2025 Q2	$119K	Buy	+16,306	New	+$132K	﹤0.01%	1073
2024 Q4	–	Sell	-45,800	Closed	-$676K	–	1525
2024 Q3	$676K	Buy	+45,800	New	+$717K	0.02%	585
2024 Q2	–	Sell	-29,300	Closed	-$461K	–	1482
2024 Q1	$461K	Buy	+29,300	New	+$452K	0.02%	565
2023 Q4	–	Sell	-4,200	Closed	-$52K	–	1529
2023 Q3	$52K	Buy	+4,200	New	+$62.5K	﹤0.01%	944
2023 Q2	–	Sell	-10,800	Closed	-$188K	–	1615
2023 Q1	$188K	Sell	10,800 -18,900	-64%	-$269K	0.01%	601
2022 Q4	$274K	Buy	+29,700	New	+$277K	0.02%	670
2022 Q2	–	Sell	-200	Closed	-$2K	–	1445
2022 Q1	$2K	Buy	+200	New	+$4.21K	﹤0.01%	974

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Aquatic Capital Management's NEO Position: Q1 2026 in Review

Aquatic Capital Management sold out of NeoGenomics (NEO) in Q1 2026, closing a stake of 12,668 shares — an estimated $149K sold.

Aquatic Capital Management first reported a position in NEO in Q1 2022 and held it in 8 quarters. The position peaked at $676K in Q3 2024. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

Aquatic Capital Management reported no remaining NeoGenomics position as of Q1 2026 after selling out during the quarter.
Aquatic Capital Management sold 12,668 NeoGenomics shares in Q1 2026, an estimated $149K.
Aquatic Capital Management first reported a position in NeoGenomics in Q1 2022 and held it in 8 quarters.
Aquatic Capital Management's NeoGenomics position peaked at $676K in Q3 2024.
253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.